chevron_left Categories

Other related webinars

Are Genes Patentable in the United States? (A Re...

Friday, 26th August, 2011
Time : 02:00 PM | 11:00 AM

GLP Regulations – A Simplified Overview for Ac...

Friday, 2nd December, 2011
Time : 02:00 PM | 11:00 AM

Understanding FDA Guidance on GLP for Nonclinica...

Thursday, 22nd December, 2011
Time : 02:00 PM EST | 11:00 AM PST

FDA and EMA successful development and approvals...

Friday, 22nd June, 2012
Time : 02:00 PM EST | 11:00 AM PST

Strategic insights into European (CHMP/EMA) and ...

Monday, 3rd December, 2012
Time : 02:00 PM EST | 11:00 AM PST

FDA Approvals and Insights: Understanding US-FDA...

Friday, 1st March, 2013
Time : 02:00 PM IST | 09:30 AM CET

Effective Responses to FDA Warning Letters on Qu...

Friday, 15th August, 2014
Time : 01:00 PM | 10:00 AM

FDA’s view of Purchasing Controls, regulatory ...

Friday, 3rd October, 2014
Time : 01:00 PM EST | 10:00 AM PST

A review of the FDA’s oversight, regulatory re...

Friday, 16th January, 2015
Time : 01:00 PM EST | 10:00 AM PST

Preparing for and Managing EU Notified Bodies Au...

Thursday, 28th January, 2016
Time : 01:00 PM EDT | 10:00 AM PDT

Biopharmaceutical Method Transfer – Using a Qu...

Friday, 20th May, 2016
Time : 01:00 PM EDT | 10:00 AM PDT

Quality systems for Analytical Instrumentation a...

Friday, 24th June, 2016
Time : 01:00 PM EDT | 10:00 AM PDT

Effective Investigation of Deviations & Putting ...

Friday, 2nd September, 2016
Time : 04:00 PM IST | 11:30 AM BST

NO More Written Procedure (Standard Operating Pr...

Friday, 14th October, 2016
Time : 01:00 PM EDT | 10:00 AM PDT

Best Practices in Supplier Management: Evaluatio...

Friday, 20th January, 2017
Time : 10:00 AM EST | 04:00 PM BST

Using Quality Indicators for Successful FDA QSR ...

Friday, 10th February, 2017
Time : 04:00 PM IST | 11:30 AM BST

Effective Management Reviews for FDA and Managem...

Friday, 21st April, 2017
Time : 01:00 PM EDT | 10:00 AM PDT

FDA Internal Audits - An Important Tool for Avoi...

Friday, 30th June, 2017
Time : 04:00 PM IST | 11:30 AM BST

FDA Regulatory Rules for Supply Chain and Manufa...

Friday, 4th August, 2017
Time : 11:00 AM EDT | 08:00 AM PDT

FDA - Training Modules

Friday, 28th September, 2018
Time : Set the Time | Set the Time

FDA Quality Systems Inspection Technique (QSIT) ...

Friday, 26th October, 2018
Time : 01:00 PM EDT | 10:00 AM PST

Key Element of Quality Management System Complia...

Friday, 30th August, 2019
Time : 04:00 PM IST | 11:30 AM BST

A CAPA Primer - Elements of a CAPA Program

Friday, 28th February, 2020
Time : 01:00 PM EST | 10:00 AM PST

How To Respond To FDA 483s

Wednesday, 2nd March, 2022
Time : 01:00 PM EST | 10:00 AM PST

FDA Expectations from Supplier Management for GM...

Friday, 22nd April, 2022
Time : 01:00 PM EDT | 10:00 AM PDT

The clinical, regulatory and business challenges...

Friday, 19th August, 2022
Time : 01:00 PM EST | 10:30 AM PST

The FDA CGMP and Data Integrity in Pharmaceutica...

Friday, 7th April, 2023
Time : 01:00 PM EST | 10:30 AM PST

FDA PMA Submissions - Contents, Process, Pitfall...

Friday, 21st April, 2023
Time : 01:00 PM IST | 10:00 AM PST

Complaint Handling in Compliance with FDA and IS...

Friday, 26th May, 2023
Time : 01:00 PM EST | 10:00 AM PST

Recorded Webinar

NO More Written Procedure (Standard Operating Procedure - SOP) Related Observations, Citations or as an Annual Top Ten FDA Observation Finding; Completely Achievable With the Provided Knowledge, Skills, Techniques and Methods

timelapse 60 mins with 10-15 mins of Q and A

Note:

This webinar occured in the past
Along with recorded webinar, copy of presentation slides will be shared
Recorded Webinar can be played unlimited times

Speaker/Presenter

Short Abstract

Per the Code of Federal Regulations (CFR), Title 21 CFR Part 211, “procedure” is stated 71 times and “Written procedures shall be followed” is stated 19 times within Subpart B-Organization and Personnel, Subpart C-Buildings and Facilities, Subpart E-Control of Components and Drug Product and Containers, Subpart-F Production and Process Control, Subpart-G Packaging and Labeling Control, Subpart H-Holding and Distribution, Subpart-I Laboratory Controls, Subpart-J Records and Reports. Clearly, the emphasis placed on procedural expectations within the CFR is indicative of the importance of written procedures, as they are the quintessential GMP foundation for an organization to control validated processes and have traceability to meet all other GMP requirements, from GMP documentation, maintaining GMP compliance, during both commercial operations, research and development, deviation investigation management, effective Corrective Actions Preventive Actions (CAPA) management, change controls, clinical and regulatory affairs, training to an essential role in managing human error. Use the knowledge and tools provided in this course to start moving your organization from “reactive/CA” focused tasks to “preventive/PA” tasks.

A preventive focused organization will reap substantial financial benefits, successful regulatory audits and even increased employee moral and retention, all are COST SAVINGS, while most importantly, increasing protection of public health!

Areas Covered in Webinar:

  • DISCOVER a proven method to ensure Standard Operating Procedures (SOPs) are Title 21 CFR Part 211 compliant, able to be followed and are always followed
  • INCREASE depth of staffs’ GMP knowledge and ability to successfully apply, create & maintain compliant quality systems
  • LEARN how to conduct Task Analysis for controlled instructional documents
  • KNOW how to design an effective and compliant document control system
  • LEARN and IMPLEMENT a method, proven successful for 20+ years in North America Commercial Nuclear and Military Aviation, prescribing procedure usage rules, which includes accounting for the environment in which the procedures must be used in order to be followed (human factored), define use of error prevention techniques during review and approval because “…shall be followed is a directive, NOT a method to achieve “…shall be followed.”


Apply for this webinar

Content Disclaimer

Contents in our website are from external websites. Links to and content from external website are provided for the convenience of users. Biopractice.com takes no responsibility for the content of such links and websites.

//